Efficacy of concurrent cetuximab (C225) versus 5-fluorouracil/carboplatin (5FU/CBDCA) or cisplatin (CDDP) with intensity-modulated radiation therapy (IMRT) for locally advanced head and neck cancer (LAHNSCC).
Lauren Quinn Shapiro
No relevant relationships to disclose
Eric Jeffrey Sherman
Consultant or Advisory Role - Bristol-Myers Squibb
Lawrence Koutcher
No relevant relationships to disclose
Jeremy Setton
No relevant relationships to disclose
Zhigang Zhang
No relevant relationships to disclose
Weiji Shi
No relevant relationships to disclose
Shyam S. Rao
No relevant relationships to disclose
Matthew G. Fury
Research Funding - Bristol-Myers Squibb
Suzanne L. Wolden
No relevant relationships to disclose
Dennis Kraus
Honoraria - Ethicon
David G. Pfister
Research Funding - ImClone Systems
Nancy Y. Lee
No relevant relationships to disclose